Bixiye
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2691 - 2700 ee natiijooyinka 3607
Bixiye
IBS-D (Lotronex, Viberzi) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Resmetirom - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Peginterferon and Ribavirin - Medicaid
Prior Authorization
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Xolremdi (mavorixafor) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Xolremdi (mavorixafor) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Caafimaad iyo Ladnaan
2025 Women's Preventive Contraceptive Benefits
Caafimaad iyo Ladnaan
2025 Detailed Description of Preventive Services